LSD microdosing - A repeated dosing study

Randomized, double-blind, placebo-controlled trial testing repeated low doses of LSD (15 µg) versus placebo in healthy volunteers over a four-week repeated dosing schedule to assess mood and subjective effects.

Secondary outcomes include measures of cognitive performance and changes in neuroplasticity; safety assessments and standard laboratory screening are used to determine eligibility and monitor adverse events.